Exploding Head Syndrome Treatment Market

Exploding Head Syndrome (EHS) is one type of parasomnia that occurs during the transition between sleep and waking. EHS is known to interfere with the sleep of affected individuals on the day of an episode.In many events, common reported noises during EHS include gunfire, door slamming, explosion etc.
Exploding Head Syndrome Treatment Market contains market size and forecasts of Exploding Head Syndrome Treatment in Global, including the following market information:
Global Exploding Head Syndrome Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Exploding Head Syndrome Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Anticonvulsants Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Exploding Head Syndrome Treatment include Arena Pharmaceuticals, Boehringer Ingelheim, Fabre-Kramer Pharmaceuticals, Jazz Pharmaceutical, Merck & Co, Glaxo Smith Kline, Respirerx Pharmaceuticals and Neurocrine Biosciences, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Exploding Head Syndrome Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Exploding Head Syndrome Treatment Market, by Drug Type, 2017-2022, 2023-2028 ($ millions)
Global Exploding Head Syndrome Treatment Market Segment Percentages, by Drug Type, 2021 (%)
Anticonvulsants
Tricyclic Antidepressants
Calcium Channel Blockers
Others
Global Exploding Head Syndrome Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Exploding Head Syndrome Treatment Market Segment Percentages, by Application, 2021 (%)
Seizures
Middle Shift Ears
Sleep Disorders
Drug Side Effects
Others
Global Exploding Head Syndrome Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Exploding Head Syndrome Treatment Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Exploding Head Syndrome Treatment revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Exploding Head Syndrome Treatment revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Arena Pharmaceuticals
Boehringer Ingelheim
Fabre-Kramer Pharmaceuticals
Jazz Pharmaceutical
Merck & Co
Glaxo Smith Kline
Respirerx Pharmaceuticals
Neurocrine Biosciences